- UHRA Home
- Browsing by Author
Browsing by Author "Mamas, Mamas A."
Now showing items 1-2 of 2
-
Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients
Khan, Nazish; Mamas, Mamas A.; Moss, Alexandra; Gorog, Diana A.; Nightingale, Peter; Armesilla, Angel; Smallwood, Andrew; Munir, Shahzad; Khogali, Saib; Wrigley, Ben; Cotton, James M. (2020-09-10)Aspirin, the most commonly prescribed antiplatelet agent in clinical practice, forms a cornerstone of management in patients with established cardiovascular disease (CVD). The clinical efficacy and safety of aspirin when ... -
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention
Deepak, Bhatt; Kaski, Juan Carlos; Delaney, Sean; Alasnag, Mirvat; Andreotti, Felicita; Angiolillo, Dominick J.; Ferro, Albert; Gorog, Diana; Lorenzatti, Alberto; Mamas, Mamas A.; McNeil, John; Nicolau, José C; Steg, Gabriel Philippe; Tamargo, Juan; Doreen, Tan; Valgimigli, Marco (2021-05-15)Aims: Choosing an antiplatelet strategy in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) at high bleeding risk (HBR), undergoing post-percutaneous coronary intervention (PCI), is complex. We ...